Nuvation Bio
Price & Volume
Stats
See more52W Range | $1.54-$3.97 |
Market Cap | $762.1M |
Shares Short | 56M |
Financials
See moreRevenue (12 Mos) | $10.9M |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $1.7M |
Diluted EPS | -$2.20 |
News
See moreYahoo Finance • 13 days ago
Nuvation Bio's SWOT analysis: IBTROZI approval boosts stock prospects
Yahoo Finance • last month
Nuvation Bio price target lowered to $6 from $10 at RBC Capital
Yahoo Finance • last month
Nuvation Bio's SWOT analysis: FDA approval boosts stock prospects
Yahoo Finance • last month
Nuvation Bio granted FDA approval for lung cancer therapy Ibtrozi
About
CEO | Dr. David T. Hung M.D. |
CFO | Mr. Philippe Pierre Sauvage |
Address | 1500 Broadway, New York, NY, United States, 10036 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 273 |
